Guatemala vs Poland: The number of people with susceptibility test result for rifampicin
Guatemala
2,022
in 2021
Poland
2,415
in 2021
Guatemala rank
46th
Poland rank
43rd
The number of people with susceptibility test result for rifampicin over time
- Guatemala
- Poland
How they compare
Poland currently reports 2,415 against 2,022 in Guatemala, a difference of 393.
That makes Poland's figure about 1.2 times Guatemala's.
Across all 5 years both countries report, Poland has been ahead every year.
Guatemala ranks 46th and Poland ranks 43rd of 155 countries.
Poland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guatemala | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,126 | 3,229 | 2,103 | Poland |
| 2020s | 1,352 | 2,216 | 864 | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guatemala or Poland?
- Poland, at 2,415 against 2,022 in Guatemala as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guatemala and Poland?
- 393, with Poland ahead.
- How many years of comparable data are there for Guatemala and Poland?
- 5 years are reported by both, from 2017 to 2021.
- How do Guatemala and Poland rank globally for the number of people with susceptibility test result for rifampicin?
- Guatemala ranks 46th and Poland ranks 43rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.